H.R. 1300 · 119th Congress

PSA Screening for HIM Act

Introduced on Feb 13, 2025 by Neal P. Dunn (R-FL-2). 38 cosponsors, 31 of them from another party. Latest action (Feb 13, 2025): Referred to the House Committee on Energy and Commerce.

Stage
Introduced
Introduced
Feb 13, 2025
Cosponsors
38
31 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for prostate cancer screenings without the imposition of cost-sharing requirements, and for other purposes.

Subjects

  • Cancer
  • Health care costs and insurance
  • Health promotion and preventive care
  • Medical tests and diagnostic methods
  • Minority health

Summary

By the Congressional Research Service (Introduced in House, Feb 13, 2025). Public domain.

Prostate-Specific Antigen Screening for High-risk Insured Men Act or the PSA Screening for HIM Act

This bill requires private health insurance plans to cover evidence-based, preventive care and screenings for prostate cancer that are not already covered under the recommendations of the U.S. Preventive Services Task Force for certain men.

Specifically, plans must cover such care and screenings for men who are age 40 and over and are at high risk of developing prostate cancer (e.g., with a family history of prostrate cancer). Such coverage must be provided without imposing any cost-sharing requirement.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Neal P. DunnR-FL-2Sponsor

Democrats · 31

Republicans · 7

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Feb 13, 2025Introduced in House
  2. Feb 13, 2025Introduced in House
  3. Feb 13, 2025 · HouseReferred to the House Committee on Energy and Commerce.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. Astellas Pharma US, Inc.11 reports
    $4.2M reported (all issues)Federal contractor: ASTELLAS PHARMA US, INC.AI match · 100%
  2. American Cancer Society Cancer Action Network, Inc.6 reports
    $12.7M reported (all issues)
  3. Dana-Farber Cancer Institute6 reports
    $379.7K reported (all issues)Federal contractor: DANA-FARBER CANCER INSTITUTE, INC.$933K in contracts, FY2026AI match · 100%
  4. ZERO Prostate Cancer6 reports
    $833.7K reported (all issues)
  5. AMERICAN ASSOCIATION OF NURSE PRACTITIONERS3 reports
    $1.4M reported (all issues)
  6. AMERICAN UROLOGICAL ASSOCIATION, INC.2 reports
  7. Dendreon Pharmaceuticals, LLC2 reports
  8. LANTHEUS HOLDINGS INC2 reports
    $662K reported (all issues)
  9. AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)1 report
    $4.8M reported (all issues)

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.